BUENOS AIRES, ARGENTINA - JANUARY 28: Airport workers transport vaccine containers through the runway after being unloaded from Airbus 330-200 of Aerolineas Argentinas at Ministro Pistarini International Airport carrying the third batch of Sputnik V vaccines from Russia on January 28, 2021 in Buenos Aires, Argentina. According to official reports, the shipment contains 220,000 doses for Argentina and an extra batch of 6,000 that will be delivered to Bolivia. (Photo by Marcos Brindicci/Getty Images)

MOSCOW, February 12. /TASS/. The Russian Direct Investment Fund (RDIF) has confirmed registration of the anti-coronavirus vaccine Sputnik V in Montenegro and Saint Vincent and the Grenadines, the Fund said in a statement.

“The Russian Direct Investment Fund announces the approval of Russian Sputnik V vaccine against coronavirus in Montenegro and Saint Vincent and the Grenadines. In total, 26 countries have already authorized Sputnik V. Saint Vincent and the Grenadines is the first island nation of the Caribbean to register Sputnik V,” the statement said.

The vaccine was approved in Montenegro and Saint Vincent and the Grenadines under the emergency use authorization procedure without additional local clinical trials.

Sputnik V was approved earlier in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia and Bahrain.

Moreover, the Russian preparation is one of the world’s top three coronavirus vaccines in terms of the number of approvals issued by government regulators. It is the third after those produced by Pfizer and Astra Zeneca (35 and 31 countries, respectively).